000 01468 a2200313 4500
005 20250516223357.0
264 0 _c20150511
008 201505s 0 0 eng d
022 _a1433-2965
024 7 _a10.1007/s00198-014-2789-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTadrous, M
245 0 0 _aComparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen.
_h[electronic resource]
260 _bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_cNov 2014
300 _a2671-2 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aGastrointestinal Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aOsteoporosis
_xdrug therapy
700 1 _aMamdani, M M
700 1 _aJuurlink, D N
700 1 _aKrahn, M D
700 1 _aLévesque, L E
700 1 _aCadarette, S M
773 0 _tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_gvol. 25
_gno. 11
_gp. 2671-2
856 4 0 _uhttps://doi.org/10.1007/s00198-014-2789-z
_zAvailable from publisher's website
999 _c24017070
_d24017070